Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Magellan Health Inc    MGLN

MAGELLAN HEALTH INC (MGLN)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
The feature you requested does not exist. However, we suggest the following feature:

Magellan Health : Named to the Fortune 500 List of America's Largest Companies

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/31/2018 | 08:57pm CEST

By a News Reporter-Staff News Editor at Journal of Engineering -- Magellan Health, Inc. (NASDAQ: MGLN) announced that it has been named to the annual Fortune 500 list of America's largest corporations by revenue for the first time in the company's history. This year marks the 64th running of the list which began in 1955. Fortune announced the selection of Magellan Health, and other companies, here.

"It is such an honor for all of us at Magellan to be among this list of impressive and innovative companies that represent the very best in America," said Barry M. Smith, chairman and chief executive officer of Magellan Health. "At Magellan, we will continue to innovate and introduce products that resonate, disrupt the industry and continue to make a difference in people's lives."

Magellan is a leader in managing complex population health, concentrating on all areas across healthcare and pharmaceutical management. With over 10,000 employees and a 2017 revenue of $5.8 billion, Magellan's consumer-centric model of care achieves improved outcomes by integrating healthcare across physical, behavioral and pharmaceutical services. Magellan also manages the highest trend components of healthcare expenditures using agile, clinically based technology and applying advanced analytics in its development of next-generation solutions.

Magellan has also differentiated itself in the specialty drug management space. Today, roughly half the total pharmacy spend is driven by specialty drugs, with half of that specialty spend covered under medical benefits, which is typically unmanaged by pharmacy benefit managers or health plans. The company has pioneered innovative strategies to tackle the high-trend areas of specialty and medical pharmaceuticals and continues to offer high-touch clinical programs focused on improved outcomes and value.

"This recognition speaks to the dedication of our associates who serve our members and customers each day with a focus on leading humanity to healthy, vibrant lives," said Smith. "We are unique in our model of care that's both high-touch and high-tech, supported by an innovative and inclusive culture."

According to Fortune, in 2018 companies on the 500 list represent two-thirds of the U.S. GDP with $12.8 trillion in revenues, $1.0 trillion in profits, $21.6 trillion in market value, and employ 28.2 million people worldwide. About Magellan Health: Magellan Health, Inc. is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. For more information, visit MagellanHealth.com.

MGLN-GEN View source version on businesswire.com: https://www.businesswire.com/news/home/20180521005648/en/

Keywords for this news article include: Business, Technology, Magellan Health Inc..

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC

(c) 2018 NewsRx LLC, source Science Newsletters

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MAGELLAN HEALTH INC
05/31MAGELLAN HEALTH : Named to the Fortune 500 List of America's Largest Companies
AQ
05/29MAGELLAN HEALTH : Elects Two New Board Members
BU
05/25MAGELLAN HEALTH INC : Submission of Matters to a Vote of Security Holders, Other..
AQ
05/22MAGELLAN HEALTH : to Participate at Jefferies 2018 Global Healthcare Conference
BU
05/21MAGELLAN HEALTH : Named to the Fortune 500 List of America’s Largest Compa..
BU
05/18MAGELLAN HEALTH : Opens a Toll-Free Crisis Line to Provide Free Counseling and R..
BU
05/02MAGELLAN HEALTH : to Participate at Bank of America Merrill Lynch Health Care Co..
BU
05/01MAGELLAN HEALTH INC : Today's Research Reports on Trending Tickers: Magellan Hea..
AC
05/01MAGELLAN HEALTH TO PARTICIPATE AT HL : The Future of Healthcare Conference
BU
04/26MAGELLAN HEALTH : Management's Discussion and Analysis of Financial Condition an..
AQ
More news
News from SeekingAlpha
06/10BULLETPROOF INVESTING PERFORMANCE UP : Week 28 
05/25Magellan to buy back additional $200M of stock 
05/01Premarket analyst action - healthcare 
04/26Magellan Health's (MGLN) CEO Barry Smith on Q1 2018 Results - Earnings Call T.. 
04/26HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am (04/26/2018) 
Financials ($)
Sales 2018 7 595 M
EBIT 2018 232 M
Net income 2018 125 M
Debt 2018 -
Yield 2018 -
P/E ratio 2018 20,12
P/E ratio 2019 16,80
Capi. / Sales 2018 0,31x
Capi. / Sales 2019 0,31x
Capitalization 2 358 M
Chart MAGELLAN HEALTH INC
Duration : Period :
Magellan Health Inc Technical Analysis Chart | MGLN | US5590792074 | 4-Traders
Technical analysis trends MAGELLAN HEALTH INC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 104 $
Spread / Average Target 6,6%
EPS Revisions
Managers
NameTitle
Barry M. Smith Executive Chairman & Chief Executive Officer
Jonathan N. Rubin Chief Financial Officer
Karen Amstutz Chief Medical Officer
Srinivas Koushik Chief Technology Officer
Michael S. Diament Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MAGELLAN HEALTH INC1.40%2 358
UNITEDHEALTH GROUP16.11%244 925
ANTHEM INC8.66%62 279
AETNA5.05%61 151
CIGNA-14.36%42 312
HUMANA23.74%42 007